Table 2 Patient characteristics at the time of medication initiation
Variable | CLZ N = 114 | OLZ N = 465 | RIS N = 350 | QUE N = 178 | ZIP N = 25 | PER N = 41 | High N = 320 | Med N = 140 | Low N = 74 | HAL+AC N = 114 |
|---|---|---|---|---|---|---|---|---|---|---|
Mean age, years | 37.3 | 41.6 | 40.3 | 39.6 | 37.6 | 40.1 | 39.0 | 40.2 | 37.9 | 38.2 |
Male, % | 57.0 | 60.2 | 54.6 | 47.2 | 24.0 | 56.1 | 58.8 | 60.0 | 64.9 | 57.0 |
African American, % | 24.6 | 40.4 | 38.3 | 34.8 | 12.0 | 39.0 | 46.3 | 35.0 | 33.8 | 41.2 |
Substance use disorder, % | 21.9 | 31.2 | 30.3 | 21.4 | 36.0 | 31.7 | 37.5 | 25.7 | 39.2 | 36.8 |
Psychiatric hospitalization in prior 2 months, % | 43.0 | 23.4 | 31.2 | 20.2 | 20.0 | 19.5 | 42.5 | 32.1 | 31.1 | 45.6 |
Mean time from study start to initiation, days | 7000.3 | 656.0 | 689.7 | 828.4 | 1403.6 | 635.8 | 604.6 | 646.8 | 622.1 | 612.7 |
Schizoaffective disorder, % | 34.2 | 32.0 | 34.3 | 39.9 | 60.0 | 29.3 | 32.2 | 37.1 | 33.8 | 32.5 |
Mean time on any antipsychotic in prior 2 months, days | 51.6 | 49.1 | 46.4 | 55.7 | 57.8 | 38.3 | 44.8 | 42.7 | 49.2 | 46.8 |